Physician profile
Andy C Chiou
NPI 1063454197
$1,403.90
in general payments reported to CMS, 2019-2025
9 companies · $95.96 in 2025
The $95.96 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $236 · 2021: $241 · 2022: $165 · 2023: $200 · 2024: $187 · 2025: $95.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $596.29 | 2019-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $186.00 | 2020 | |
| Angiodynamics, INC. | $143.79 | 2019 | |
| Tactile Systems Technology INC | $120.69 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Kerecis Limited | $103.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mindray Ds USA, INC. | $95.96 | 2025 | Te7 Max, Te X |
| Medtronic Vascular, INC. | $74.24 | 2019-2020 | |
| Medtronic, INC. | $62.21 | 2023-2024 | Intellis Adaptivestim |
| Philips North America LLC | $20.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Chiou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.